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T he administration of pyrogenic doses of interl eukin 1 (IL-
1) to norm al m ice before contact sensiti za tion with dini-
troAuorobenzene (ONFB) resu lted in a signifi ca nt reduc-
tion in the intensity of the elicited contact hypersensitivity 
(CH) responses . Adoptive transfer experiments es tablished 
no difference between no rm al and IL-l-pretreated mice 
rega rding their capacity to generate splenic suppressor-cell 
activity and lymph node effecto r-ce ll activity in response 
to ONFB. However, a marked reduction in the intensity 
of elicited responses was observed when prim ed C H-ef-
fector ce ll s, obtained from no rmal donors, were adoptively 
transferred to IL-1-pretreated recipients . This findin g was 
paralleled by a consistent redu ction in the ability of the 
ado pti vely transferred cell s to infiltrate the ti ss ue sites of 
anti gen challenge in the IL-l -pretreated animals. Treatment 
of mice with indomethac in , a potent inhibito r o f prosta-
E xposure of mice to ultravio let radiat ion (UVR) ca uses a depression in their ab ility to elicit contact hypersen-sitivity (C H) responses to topi ca ll y appli ed skin-re-ac tive chemi ca ls [1 ,2'1. This depression in reactivity occurs not o nl y when the contact sensitizing (CS) agent 
is app lied directl y to the irradiated skin site, but also when the 
hapten is applied to no n irradi ated skin sites [J-5J. T he latte r phe-
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Abbreviations: 
C H: contact hypersensiti vity 
CS: contact sensitizing 
DNFB: dinitroAuorobenzene 
ETAF: epidermal cel l-deri ved thymocyte acti vating fac tor 
FCS: feta l ca lf serum 
IL- l : interi cukin 1 
LPS: lipopolysaccharide 
PMN : polymorphonuclear leukocyte 
SAP: serum amyloid-P 
sci L-1: stratum co rneu m-deri ved ET AF/ IL-l 
UVR: ultraviolet radiation 
glandin produ ction , abroga ted the capacity of IL-1 to de-
press C H responses folJ owing skin sensitization with ONFB. 
Simi larly, indom ethacin was also capable of abroga ting the 
ability of IL-1 to depress CH responses of adoptive recip-
ients of primed CH-effector cell s. Our results indica te that 
the capacity of IL-1 to depress CH responses in normal 
mice is due to an indomethacin-sensiti ve process, presum-
ably mediated through the IL-1-induced generation and 
action of prostaglandins. T his w as supported by our find-
in g that treatment of mice with arachidonic acid or pros-
taglandin E2 ca used a similar type of inhibition. The mech-
anism(s) responsibl e for this effect appears to act at the 
efferent level of the C H response, as evidenced by the 
reduced ca pacity ofCH-effector cells to infiltrate the tissue 
sites of antigen cha llenge. J Invest Der/'/'latoi 88:380-387, 
1987 
no meno n has been referred to as a systemi c depressio n of CH 
res po nses and requires large doses of UVR for elicitation [4,5]' 
A similar type of sys temic depression in immune res ponsiveness 
that has recentl y been described occurs when the inA ammarory 
agent lipo po lysaccharide (LPS) is admini stered to anim als before 
the topica l appli ca tion o f skin-reactive chemi cals [6]. Lipopoly-
saccharides and UVR are po tent induce rs of inAamm atory re-
sponses in vivo and are bo th ca pable of inducing the production 
of th e multifun ctional hormone, interleukin 1 (lL-1) [6-11]. 
Since both UVR and LPS stimulate IL-I produ ctio n in vivo, 
the questi on was rai sed as to w hether IL-1 itself had the ca pacity 
to depress C H res po nses in vivo. Our preli minary results [6] have 
demonstrated that th e i. v . administrat ion of pyrogeni c doses of 
IL-1 to norm al mi ce depressed a subsequent immunologic re-
sponse to the CS agent dinitroAuorobenzcne (DNFB) . In this 
repo rt we describe the res ults of experim ents that were designed 
to elu cidate the Illechani sm(s) by w hi ch IL-1 depresses the inten-
sity of C H responses to CS agents. 
MATERIALS AND METHODS 
Experimental Animals C3H / HeN-strain mi ce of both sexes 
were obta ined from th e Animal Production Facility, N ational 
In stitutes of Hea lth . All mi ce were housed at a maximum density 
of 5 animals per 7 x 1'1 inch cage and maintained on Wayne 
Steriliza ble Lab B lox and acidifi ed water ad libitum . Animals were 
sex matched and 8-1 2 weeks o ld at the onset o f any given ex-
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periment. Four to five animals were employed within each ex-
perimental group . Most experiments were repeated at least twice 
with similar results. 
Sources of Epidermal Cell-Derived Thymocyte Activating 
Factor (ET AF)/IL-1 Purified human IL-1 purchased from 
Genzy me (Boston , Massachusetts) was used as a standard to quan-
ti tate the activity of ETAF/ IL-1 used in these studies. This ma-
terial is provided by the manufacturer, in a form stabilized with 
fe tal calf serum (FC S), and is therefore unsuitable for in vivo 
studies. The ETAF/ IL-l employed in most of the in vi vo studies 
reported herein was prepared fro m human heel callus stratum 
corneum and semipurified as described previously [1 2J. Stratum 
corneum-deri ved ETA F/ IL-l (sclL-l) is to tall y free o f any inter-
leu kin 2, interleukin 3, and any other colon y-.stimulating activities 
(W. E. Samlowski et aI, submitted for publication) and provides 
an easy and inexpensive source of high-specific-activity material 
for in vivo and in vitro bioassays o f ETAF/ IL-l mediated effects. 
Recombinant human IL-l was employed in selected in vivo ex-
periments to verify that the effects being observed were not due 
to a minor contaminant in the stratum corneum-derived prepa-
ration. This material was generously provided by Dr. Robert 
Newton (duPont de Nemours & Company, Glenolden, Penn-
sylvania). 
Prostaglandin and Arachidonic Acid Prostaglandin E2 was 
purchased from Upjohn Co. (Kalamazoo, Michigan) and diluted 
Immediately befo re use to a concentration of 100 p.g/ml. Arach-
Idonic acid-containing pellets were obtained from Innovative Re-
search of America (Rockville, Maryland) and are designed to 
release approximately 375 p.g/day over a 20-da y period following 
subcutaneous implantation . 
Prostaglandin Inhibitors Pellets containing specified doses of 
indomethacin were obtained from Inno vative Resea rch of Amer-
ica. The pellets were inserted subcutaneously by troca r 24-48 h 
before initiatin g an ex perim ental protocol , and have the capacity 
to slowly release the inco rporated dru g at a constant rate (1. 25-2.5 
JLg/day) over a 20-day period . 
In Vivo Analysis ofETAF/IL-l-Mediated Effects Core body 
temperature o f C3H/ HeN mice was determined 20 min post in-
jection of ETAF/ IL-l using a rectal probe and a YSI Digital 
Telethermo meter (Model49T A, Fisher Scientific Co ., Pittsburgh, 
Pennsylvania). C irculating murine neutrophils were quantitated 
24 h post injection of ET AFIIL-l-containing preparations by the 
removal of 50 p.l of blood from each ex perimental and control 
mouse in heparinized capillary tubes. The total number of leu-
kocytes was determined with a hemocytometer and diffe rential 
analysis o f leukocytes was performed on Wright 'S stained blood 
smears. Plas ma obtained from ex perimental mice 24 h post in-
jection of ETAF/ IL-l w as assayed quantitativel y fo r se rum am y-
loid-P (SAP) by radial immunodiffusion employing a rabbit an-
ti murine SAP antibody [7] . 
Sensitization and Elicitation of Contact Hypersensitivity 
Normal mice were sensitized by applying 25 p.l of 0.25% DNFB 
(Sigma C hemical Co., St. Louis, Missouri) in a 4:1 acetone:oli ve 
oil mixture to the shaved ventral surface on day 0 and day 1. The 
presence o f C H was established by applying 10 p.l of the solution 
to the ri ght car on day 4. The extent of swelling was used as a 
measure of C H and is expressed as the diffe rence in thickness 
between the challenged right and unchallenged left ea r as mea-
sured with an engineer's micrometer (Mifutoyo, J apan) 24 and 
48 h followin g challenge. The percent depression of C H responses 
caused by [L-l administration was calculated from the formula: 
01 d . 1 experim ental - challenge only 
10 epresslOn = - x 100 positive control challenge only . 
Adoptive Transfer of Suppressor Cells N ormal mice or mice 
that had been injected i. v. with a pyrogenic dose of IL-l 24 h 
previously were sensitized with 25 p.l of a 25% DNFB solution 
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in aceto ne:o live o il (4:1 ) on the shaved abdomen and 10 JLI on 
each footpad and ear on da y 0 and day 1. Four days following 
sensitiza tion, spleens were surgica ll y excised and gentl y disso-
ciated in RPMI 1640 (Durchland Labo ratory Animals, Inc., Den-
ver, Pennsy lvania) supplemented with 5% FC S (Hy-Clone Sterile 
Systems, Inc., Logan, Utah). The resulting single cell suspension 
was transferred i.v. in to norm al recipient mice (1 x 108 
cellslrecipient) . Recipients were sensitized with 0.25% D NFB on 
their shaved abdomen 1 h and 24 h foll owing splenocyte injection. 
Fi ve days fo llowing sensiti za tion, all groups of mice were chal-
lenged by applying 10 p.1 of 0.25% DNFB to the right ear. T he 
percent suppression was ca lculated acco rding to the formula: 
% suppression 
1 
ado ptive recipient - challenge only 
= - . . x 100. 
positive control - challenge onl y 
Adoptive Transfer of Effector Cells Normal mice or mice 
that had been injected i.v . with Il-1 24 h previously were sen-
sitized with 25 p.l of a 0.25% DNFB solution in acetone:oli ve oil 
(4:1) on the shaved abdo men and 10 p.1 on each footpad and ear 
on day 0 and day 1. Four days following sensitiza tion , inguinal, 
axillary, and brachial lymph nodes were excised and gently dis-
sociated in RPMI1 640 supplemented with 5% FCS. T he resulting 
single cell suspension was transferred i. v. into normal recipient 
mice (30 x 106 cellslrecipient) that were challenged immediately 
on the ri ght ea r with 10 p.1 of a 0.25% DNFB solution . Ear 
swelling was measured 24 and 48 h fo llowing challenge. 
Effector Cell Localization Assay N ormal mice were sensi-
tized with 25 p.1 of 0.25% DNFB on the shaved abdomen and 
10 p.1 on each footpad and ear on day 0 and day 1. Four days 
following sensitiza tion , inguinal, axillary, and brachial lymph 
nodes were excised and gently dissociated in RPM! 1640 supple-
mented with 5% FCS. The lymphocyte suspension was adjusted 
to approximately lOB cells/ml in RPMI and incubated fo r 30 min 
at 37°C in the presence of 25- 50 p.C i of sodium chromate (5I C r, 
sp act 50-400 mC i/ mg C r, Amersham , Arlington Heights, Illi-
nois) . Immediately following incubation , the cells were washed 
3 times with RPMI1 640 medium to remove unbound radiolabel. 
The resulting lymphocy te mixture w as transferred i. v. in to ap-
propriate recipient mice that were challenged immediately on the 
ear with 10 p.l of a 0.25% DNFB solution . Ea r swelling was 
measured 24 h following challenge. Immediately fo llowing ear 
thi ckness measurements, the mice were sacri ficed and both ears 
were surgically excised and assayed on a Beckman gamma counter 
for the amount of 5 1C r localized to the DNFB-challenged and 
unchallenged ea rs. 
RESULTS 
Systemic Administration of IL-1 to Mice Reduces Their 
Ability to Elicit a CH Response The exposure of normal 
mice to UVR or lPS before contact sensitization causes a reduc-
tion in their capacity to elicit C H responses [3-6]. This obser-
vationled us to ques tion whether the immunodepressive ac tivities 
ofUVR and lPS might be mediated through a common pathway, 
possibly through the produ ction o f Il-l or one of the many 
known bioactivities induced by this inflammatory mediator. T o 
analyze this possibility, the effects of IL-l in vivo on the gener-
ation of C H responses were determined. Groups of normal mice 
were injected i.v. with pyrogenic doses (100, 50, or 25 units) of 
human sell-1 . T hese doses of selL-l cause an increase in core 
body temperature, stimulate the release ,of neutrophils from bone 
marrow stores, and stimulate liver hepatocy tes to produce acute 
phase pro teins (Table I) . Twenty-four hours fo llowing the admin-
istration of scll-l , the experimental groups and a group of control 
animals were contact sensitized by topical applica tion to the ab-
domen of DNFB. Five days after skin sensitiza tion all animals 
were challenged by appli ca tion of the same hapten to the ear. The 
results o f this experiment (Table II) demonstrate that the i. v. 
injeetion of sclL-l to norm al mice 24 h before skin sensitiza tion 
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Table I. In Vivo Administrati on of sC\L-l to Mice Induces an 
Acu te Phase Response 
50 Units t:J. Temp" t:J. SAP' t:J.I'MN" 
Experim e n t # In te rlc ukin I" (0C) (/Lg/ ml ) (x 10 - (' cell s/ ml) 
I + 1. 4 ± 0. 1 53 ± 5 3.'} ± 0.08 
2 + J.3 ± 0 .1 7 1 ± 2 4.4 ± 0 .34 
"Mice received a ll i. v. injection of 50 uni ts o f sel l - I. T he bioacti vity o f O llf 
preparation was com pared with a puri fIed prepa rat ion o f Il-l obtained fro m Gcn-
zy me. 
bC o rc body temperature was analyzed 20 min post injection. T he 110 rmal range 
of co re bod y te mperature in these experiments was 36.7° ± 0.2 and 36.6°C ± 
0.2. respecti vely. 
(Pe ri pheral blood samples were obtained from all tcst anima ls 24 h POSt injection 
and plasma sam ples we re analyzed for serulll amylo id- P (S AP) levels by rad ial 
immun odi ffu sio n. SA P va lu es ob tained fro m no rmal mi ce fo r bo th ex perim ents 
were 60 ± J /-' t; / 1lI1 alill 49 ± I /-,g/llii. 
' I'MN we re quantitated fro m 24-h postinjecti on pe ri pheral blood S:lIn ples. Nor-
ma l val lies were 1. 78 ± 0.1 8 X 10" cells/1ll1 and 1.8 ± 0.3 X 10" cells/ ml. 
with D N FB mark edl y redu ces their ability to elicit a C H response 
in a dose-dependent manner. Further, the exposure of a similar 
preparati on of sC\L-l to hea t (90°C for 30 min) abrogated its 
ca pacity to inhibit the developm ent of a C H res ponse. This ex-
periment has been repeated several times using both semipurifi ed 
human sc\l-l [1 2J and recombinant human Il-1 , w ith identi ca l 
results (data not shown). 
Studies of Effector and Suppressor Cell Activity in IL-l-
Pretreated Mice Contact hypersensiti vity is a cell-mediated 
immune response tlpt associatcs with both th e gcneration of ef-
fecto r cells, fo r elicita ti on, and the generat ion of supprcsso r cells 
that are bel ieved to regulate th e intensit y and durati on of this 
rcs ponse. Wc there fore ques ti oned whether the sell- l-treatcd an-
im als d iffcred fro m nOTll13ls in their ca pacity to gcnerate either 
suppressor or C H-effector ccll s in res ponse to contact sensitiza-
tion. 
To asscss suppressor cell generation , groups of norm al and 
sel l -l-pretrea ted mice were contact sensitized with D NFB . Fivc 
days later these animals were sacrificed and their spleens were 
harvcsted and di ssociated in vitro to obtain a sing lc cell suspen-
sion . Splenocy tes (1 X 108) from both dono r groups were then 
injected i. v. in to groups of naive recipients that were immediatel y 
sensitized with D N FB. All animals we re then ear-challenged w ith 
D N FB 5 days latcr. T he res ults of this stud y (Ta ble IlI A) es tablish 
that fo ll owin g D NFB sensitiza tion, signifi cant suppressor cell 
act ivit y co uld be fo und in the spleens obtained from both normal 
and sel l-l-pretreated donors. T hc ado pti ve transfer of spleno-
cytes fro m nonsensitized animals in to norm al recipients, th at werc 
T H E J O URNA L OF INV ESTIG AT IV E DERMATO LOG Y 
subsequcntl y sensitized with DNFB and challenged, had minimal 
effect on thc gcneration of C H res ponses . This findin g is con-
sistent with the observati ons made by o thers indicating that both 
UVR-ex poscd and norm al animals exhibit systemic suppressor-
cell activity subsequent to contact sensitization to topicall y applied 
haptens [1 3]. An additi onal ex periment, where serum from sclL-
1-pretreated and DN FB-scnsitized donors (0 .3 ml) was adoptively 
transferred into no rm al recipients, was found to have no sup-
pressive effect (data not shown) . 
In a parallel study we analyzed whether C H-cffector cells were 
induced in sell-l-pretrea ted animals subsequent to contact sen-
sitiza ti on. Groups of normal and Il-1-pretreated animals were 
contact scnsitized with DNFB and 5 days later their peripheral 
lymph nodes wcre harves ted and teased into single cell suspen-
sions. Thesc lymph node cells (30 X 10(') were injected i. v. into 
groups of naivc recipients, which were immediately ear-chal-
lenged with DNFB . C hanges in ear thickness were measured 24 
h following the hapten challcnge. The rcsults (Table lIIB) deter-
mined that an equivalent deg rec of effecto r-cell activity was pres-
ent in both the norm al and the scll-l-pretrea ted animals that 
were sensitized with DNFB . Therefore, it appears that selL-1-
pretrea ted animals eli cit a dcpressed C H res ponse despite the pres-
ence o f both suppresso r and effector cell ac tivity that is fun c-
tionall y equi valent to that found in norm al animals. 
InterIeukin 1 Functions by Inhibiting the Effector Arm of 
the CH Response We next questioned whether the effects of 
sell-1 on the generation of C H responses .might be associated 
with a depresscd capacity of these animals to mobilize immune 
effecto r cells to the peripheral sites of antigen challenge. Groups 
of no rm al and sell-1-pretreated animals (day - 1) received 30 X 
10(, DNFB-sensitized effector cells obtained from the peripheral 
lymph nodes of normal DNFB-primed donors. Immediately fol-
lowing lymphocyte injection, all animals were ear-challenged with 
DNFB . Changes in ea r thi ckness were measured 24 h later. The 
sell- 1-pretrea ted recipients were found to exhibit a marked re-
du ction in their capacity to elicit a C H response following the 
ado ptive transfer of DNFB-primed lymph node cells (T able IV , 
Experiment 1). The degree of inhibition in the capacity of sclL-
1-treated animals to eli cit a C H response foll owing the adoptive 
transfer ofDNFB-primed lymph node cells was most pronounced 
when the C H-effector cells were given 1 day followin g sclL-l 
treatment (T able IV, Experiment 2) . The sell-I-treated animals 
appeared to recover their ability to eli cit a C H res ponse by 1-2 
weeks post selL-l trea tment . 
The res ults of our experim ents suggested that the effects ofll-
1 on C H was due to its ca pacity to interfere with the effector ann 
of this immunologic response. To determine whether the adop-
Table II. Capacity of scll-l to Inhibit the Ability o f Mice to Generate Contact Hypersensitivity Hes ponses Is 
Dose Dependent 
Dose of DN FB DNFB t.'Ea r Percent 
G ro u p # scl L-1 " Sen sitize/, C hall e n ge" Swellin g' D epress io n(/ 
I + I ± 0.5 
2 + + 102 ± 2 .0 0 
3 100 units + + 61 ± 2 .0 41 
4 50 units + + 59 ± 3 .0 43 
5 25 units + + 95 ± 2.0 7 
6 t:J. 100 units' + + 108 ± 3.0 0 
"Twenty-four hours before D NFU sensitiza ti on m ice received an i. v. injection of approp ri ate doses of sel l - I. The bioacti vity of our preparation was com pa red with a 
puri fied preparation of Il- I obtained fro lll GcnzY l11 e. 
"M ice were sensitized to D N FB by appl yin g 25 1'-1 ofa 0.25% solution o f D N FB in o li ve o il (4: I) on th eir ventral surface . Five days fo ll owin g sensiti za tion th ese animals 
were car-chall enged wi th JO /-,1 o f 0.25% D N FB. 
'Twenty-four hours after challenge, ea r swellin g (I X 10 - 4 in ches ± SEM) was measured w ith an engineer's mi cro meter. Results arc expressed as the thickness of the 
challenged ear m inus the thickness of the unchallenged ear. 
JPcrccllt depression was calcul ated lI sing the fo llowing eq uatio n: 
. swelling (experimental) - swelling (negative control) 
% depreSSIon = I - X 100. 
swellin g (posi ti ve co ntro l) - swell ing (nega ti ve contro l) 
'The scl l - l was hea t- inactiva ted (90°C fo r 30 min) before i.v. injection . 
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Table III . N o rm al Suppressor and Effecto r Cells to DNFB Are Generated in selL- l Pretrea ted Animals 
A. Splen ocy tes from N o rm al and selL-I - Pretrea ted Mi ce D emonstrate Equivalent Suppressor C ell Activity in Res po nse to D N FB 
Group # 
I 
2 
3 
4 
5 
Trea tment of Recipient Mice" 
C hallenge only 
Sensitize plus challenge 
Adoptive transfer of spleen ce lls from DN FI3-scnsitizcd 
donors; scnsitize plus challenge 
Adoptive transfer of spleen cel ls from DNFB-sensitized 
and sel L- I-treated donors; sensiti ze plus challenge 
Adoptive transfer of splecn cel ls from untrea ted donors; 
scnsitize plus cha llenge 
Ea r Swellingb 
4 ± 2 
79 ± 2 
37 ± 2 
35 ± 
67 ± 0 
B. selL-I-Prctrea ted Mice Elicit Normal Effector Cell Res ponse Follow ing Skin Sensitiza tion With DNFB 
Group # 
1 
2 
3 
T reatment o f Recipient Mice" 
C hallenge onl y 
Adopti ve tra nsfer of lymph node cd ls from DNFB-scnsitizcd 
donors; plus challenge 
Adoptive transfer of IYll1ph node cells fro m DNFB-sensitized 
and selL-I-treated donors; plus challenge 
Ex periment # I 
3 ± 
32 ± 4 
39 ± 3 (0)' 
Percent of 
Normal Response' 
Ea r Swellin g" 
100 
44 
41 
84 
Experiment #2 
2 ± 
29 ± 
30 ± (0) 
' Recipient mice rece ived an i.v. injectio n of no rl11o l splenocy tes ( I X IU') or DNFU-sensitized sp lenocy tes ( I X 10') el icited in no rmal or sclL- I-pretrcoted (50 uni ts) 
dOllo r mi ce as described ill A4alai(1 /s (IIId N1t:, llOds. O ll e ho ur and 24 ho urs fo ll ow in g injecti o ns. n.:cipicllt mice were sens itized 0 11 their s to mach wi th :1 0.25% DNFU solutioll 
in Jcclonc:oli vc o il (4: 1). Five da ys fo llow in g sensitiza ti o n, mice were car-chall enged w ith th e sa me :1 ll tigcn. 
"Twent y-four hOllrs following challcnge. ea r swelling ( I X 10 - .1 inches ± SE M) was measurcd w ith an cng ineer's micrometcr. nesults arc expresscd :1 S the thickncss of 
the challenged cor minus the thi ckness of the unchallenged car. 
'The capa cit y to elicit a CH respo nse was calcula ted as a percen ta ge of the positive control. 
JRecipient mi ce received an i. v. i,Ij ectio n o f D N FB-sensitized IYlll phocytes (30 X 10") eli cited in nOflllJI o r selL- I-p re trea ted (50 units) do no r lII ice os described in Malerillis 
alld Methods. Imm ediatel y fo llowing lymphocy te injection. recipient lIIice were car-chall enged w ith a 0.25% DNFB so lu tion in acelOne:oli ve o il (4: I). 
tpercent dev iati o n fro m e ffector response elicited by normal dO llo rs. 
tivel y transferred effecto r cells gain access to the tissue site of 
antigenic challenge, ly mph node cell s we re obta ined fro m DNFB-
primed donors and radiol abeled by incubation with slC r before 
their transfer to no rm al o r sell-I-pretreated recipicn ts. All ani-
mals were subseq uentl y ear-challenged with DNFB. Twenty-
four ho urs fo llowin g challen ge, both the ex ten t of ea r swelli ng, 
and the amount of radioa ctivity within each ea r was quantitated 
by surg ica ll y excisin g the ea rs and coun tin g in a ga mma co unte r. 
T he results o f 3 different expe rimen ts (Table V) verified that the 
IL- I- pretreated anim als dem onstrate a m arkedl y dep ressed C H 
responsc. T his conditio n was paralleled by a signifi ca nt redu cti on 
in thc number of adoptively transferred cells ca pab le of in fi ltrating 
th e locall y induced inflammatory lesio n . T he results of these ex-
perim cnts indi ca te th at trea tm ent of anim als w ith selL- I alters the 
m o vem ent of immune effector cell s into t issue sites o f anti gen 
deposition. 
Table IV. Pretrea tm ent of N ormal Animals With sclL-l Inhibits the Ability of Adoptivel y Transferred , Antigen-Sensiti zed 
Lymph N ode Cells to M ediate Contact H ypersensitivity R esponses 
Treatment of Recipients 
Adoptive T ransfer 
of DN FB-Sensiti zed 
Experiment # Lymphocytes" scI L- I" Challenge' 
+ 
+ + 
+ (day- I) + 
2 + 
+ + 
+ (da y-I) + 
+ (day-4) + 
+ (day-7) + 
+ (day- 14) + 
tl Ear 
Swelling" 
3 ± 2 
34 ± 4 
13 ± 2 
3 ± 2 
32 ± I 
7 ± 
12 ± 
22 ± 
24 ± 
Percent 
Depression" 
o 
68 
o 
86 
69 
36 
28 
' DNFB-sensiti zed lymphocy te populations from anilll ais prepared as adoptive transfer donors as described in Mnierill is IIl1d Melh ods. Each recipient anim al received 30 X 
10" cells. 
bRecipient mi ce received an i. v. injection of 50 units IL- I at times specified before adopti ve tr:lI1s fcr procedurc . 
' Hecipient mice were ca r-challenged w ith 10 J.LI ofa 0.25% so luti o n of DNFU in acelOne:olivc o il (4: I) illlmed iOle ly fo ll owin g adoptive transfe r. 
JTwcnty-fou r ho urs fo ll ow in g challen ge. ca r sw elling ( I X 10 - 01 in ches ± SEM) was mcasured w ith all e ll g ill ccr's mi cro mctc r. Results an: cxpressed as the thi ckll ess or 
challenged car minus the thickness of un challenged car. 
' Percelll depressio n was determined using the fo llowin g equatio n: 
. swel lin g (ex perimental) - S\"e1 ling (nega tive control) 
% depreSSIOn = I - X 100. 
swel ling (pos iti ve contro l) - swel ling (nega tive con tro l) 
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Table V. Pretreatment of An imals With selL-1 Results in a Redu ced Capacity of DNFB-Sensitized Effector Cel ls to Enter Tissue 
Si tes of Antigen C hallenge 
T rea tment of Recipicnts 
Adopti ve Transfer 
of D N FB Sensitized D. Ear D. C PM in 
Expcriment # lymphocytes" sell- I" Challenge' Swelling" Challenged Ear'-
+ 2 ± 1 
+ + 35 ± 3 (O)! 1054 ± 102 (0) 
+ + + 13 ± 1 (67) 218 ± 41 (79) 
2 + 5 ± 
+ + 38 ± (0) 285 ± 3 (0) 
+ + + 13 ± (76) 100 ± 17(65) 
3 + 6 ± 2 
+ + 36 ± 1 (0) 1217 ± 129 (0) 
+ + + 15 ± 1 (70) 776 ± 89 (36) 
"DNFB-sensitized lymphocyte popu lations (rom animals prepared as adopti ve transfer donors were labeled with SlCr as described in Materill is mill Methods. Each recipient 
anim al rece ived 30 x 10" cells. 
hRecipient mice received an i.v. injection of 50 units sclL- 1 24 h befo re adoptive transfer proced ure. 
'Recipient mice were ca r-challenged with 10 ILl of a 0.25% solution of DNFB in acetone:o live oil (4 : I) immediately following adoptive transfer. 
'Twenty- four hours fo ll owing cha ll enge, ea r swelli ng (I x 10 - ' inches ± SEM) was meas ured with an engineer's microm eter. Results arc ex pressed as th e th ickness of 
the challenged ca r minus the thickn ess of the un chall enged ca r. 
'Fo ll ow in g ca r measurements , mi ce were sacrifi ced and both cars were removed and :111;') lyzcd for amo unt o f rad ioactivity. Results arc expressed as the cpm in challenged 
ca r minll s cpm in unchallenged car. 
' N um bers in parenthesis represent the percentage o f depress ion . 
The Capacity of scIL-l to Inhibit CH Responses Appears to 
Be Mediated Through the Action of Prostaglandins We 
questio ned w hether the stimul ation of prostaglandin production 
by selL-l was in volved in th e selL-1-induced depress ion of C H 
responses. We first chose to analyze this possibi lity by usin g thc 
dru g indo m eth acin , a known inhibitor of th e cyclooxygcnasc 
path way and therefore prostaglandin synth esis. B io deg radable 
pellcts that rei case approximately 2.5 fLg/day of indom ctha cin in 
v ivo o n a con tinuous basis wcre implanted subcutancously into 
g roups o f mice 48 h bcfo re the administration of 50 units of selL-
1. Twenty minutes after selL-l treatm cnt core body temperature 
was dcte rmin ed with a rectal therm o m eter, and a t 24 h blood 
from th esc anim als was analyzed for changes in the concentrati on 
of SA P and th e number of circu latin g ncutrop hil s. The data pre-
sented in Table VI determined that trcatm ent of anim als with this 
small dose of indomethacin ca used onl y a sli ght redu ction in the 
selL-1-induced fever. However, thc IL-i-induced synthesis of 
acute phase pro teins an d the release of polymo rphonucl ear leu-
kocytes (PMNs) by thc bone marrow were m arkedly red uced in 
anim als receivin g thi s type of indo m ethacin thera py. Further cx-
perim ents, employin g fa r larger doses of indo m eth acin (100 g) 
g iven i. p . at the sa m e time as the selL-1, were able to demonstrate 
that this dru g was also capab lc o f abroga ting the pyrogeni c ac-
tivity o f this cytokin e (data not shown). A da il y dose of indo-
m eth acin of 2.5 fLg was used in our experim ents to determinc 
the ro le of prostag landin s on thc immuno m odul atory activity of 
sell-1. Fifty units of sclL-1 werc inj ected i. v. into norm al micc 
o r mi cc that had previo usly been g iven a subcutaneous im plant 
of an indomethacin-con ta inin g pellet . Twenty-four ho urs fo llow-
in g the sclL-l inj ection, both g ro ups of anima ls, alo ng w ith no r-
mal cont ro ls , w ere contact sensitized by top ical appli cation of 
D N FB. Five days after skin sensitization all anim als were ea r-
cha ll engcd w ith thc sa m e hapten . The results presented in T able 
VII demonstrate that indo m ethacin treatm ent abrogatcs the ca-
pacity of IL-l to depress the development of C H responses. An 
add iti o nal ex perim ent es tablished that th e adoptive transfer of 
lymph node cells fro m DNFB-sensitized dono rs to IL-1-pre-
trea ted recipients (either sclL-1 o r hum an reco mbinant IL-l /l) al-
lowed a normal C H response if the an im als had also received an 
ind o m etha cin-containing pell et (Table VIII) . This result indi ca tes 
th at trcatment o f anim als with indo mcth acin abroga tes the effects 
of IL- l o n the recipients of antigen-primed effector cells. 
Treatment of Mice with Arachidonic Acid or Prostaglandin 
E2 Inhibits the Capacity of Normal Recipients to Elicit CH 
Responses T o furth er suppo rt the inhibitory role played by 
pros ta glandins in the effectuation ofCH responses subsequent to 
IL-1 treatment, the followin g experim en t was conducted . Groups 
of norm al mi ce were pretrea tcd with ei ther reco mbin ant human 
IL-i /l' arachid onic acid (375 fLg/day ), or PGE2 (10 fLg/day) before 
the adoptivc transfer o f DNFB-sensitizcd ly mph node lympho-
cytes. O ne half of thc an imals w ithin cach experimental group 
also receivcd an indomethacin pell et (2.5 fLg day) . All anim als 
were subsequentl y car- challenged w ith DNFB and thc m agnitude 
of ea r swelling m easured 24 h later. The res ults of this experim ent 
(Table IX) clea rl y es tablished that IL-1, arachido nic acid , and 
PGEz werc equally effective at inhibiting the capacity of the adop-
tive rccipients to eli cit normal C H response. Indo m ethacin treat-
m ent was ca pablc of ab rogatin g the IL-1- and arachid onic acid-
induccd inhibit ion , but had no effcct o n th e depression in CH 
responses caused by P GEz itself. This finding adds support to the 
hypothesis that IL- 1 excrts its modula tory activity on C H re-
sponses throu g h its ca pacity to stimul ate prostaglandin biosyn-
th csis. 
Group # 
I 
2 
3 
Table VI. Effects o f Indomethaci n on 
selL-i -Induced Acute Phase Respo nse 
D. TempI> D. SAP' D. PMN'/ 
Treatment" (0C) (JLg/ml) ( x 10 - " cells/ ml) 
sclL- 1 1. 6 ±0. 1 53 ± 5 3.9 ± 0.5 
Indo methacin o ± 0.2 9 ± 1 0.2 ± 0.3 
sclL-l and 1.7 ± 0. 1 14 ± 9 0.2 ± 0.3 
indomethac in 
"Gro ups of mice we re subcutaneously implanted by troca r with indo methacin 
pell ets that release 2.5 ILg of drug per day. Indo methacin mice were rested 48 h 
befo re i. v. inj ection of sclL- l (50 units). 
bCo re body temperature was ana lyzed 20 mi n following IL- I il~ cction s. The 
normal ran ge of co re body temperature was 36.6 ± 0. 12°C. 
'Peripheral blood sa mples were obtained 24 h post injecti on and plasma sa mples 
were ana lyzed for serum amyloid-P (SAP) levels by radial immunodiffusion. SAP 
va lues ob tained (rom normal mice were 60 ± 3 ILg/ ml. 
' PMN were quantitated from 24-h postinjection periph era l blood sa mples. N or-
mal va lues were 1.58 X 106 ± 0.04 cells/ tn!. 
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Table VII. Pre treatm ent of Anim als With Indo m ethac in Abroga tes th e sclL-1 - Indu ced Depressio n of 
Contact H y persen sitivity R espo n ses 
Group # 
I 
2 
3 
4 
5 
T rCJt llll:nt l l 
N one 
N one 
In dom eth acin 
sci L- I 
Indomethacin 
plus sci L- I 
Sensitizer, C hallen ge" 
+ 
+ + 
+ + 
+ + 
+ + 
D. EJ r Pe rccllt 
Swell ing' Depression" 
5 ± 2 
68 ± 2 0 
62 ± 2 8 
31 ± 2 59 
60 ± 2 13 
"G roups o f mi ce we re subclIt ;lJ1collsly im pla nted w ith indo l11 ethacin pd1t:rs (h al rdc;1 sc 2.5 J.Lg of drug/d:1 y. In do me th acin mice were res ted 48 h before i.v. injectio n o f 
scIL-1 (50 ullits). 
"All mice we re sensi tized to DNFU by app lyin g 25 J.Ll o ra 0.25% solution ofDNFU ill acclo llc:oiivc oil (4 : I) ("0 the ir vcn tra l surf:1cc. Five cbys fo llowing sensitization 
thesc anima ls Wl'rC c",-challcnged wi th 10 ,...1 of 0.25% DNFll. 
r'fwcnr y-fo ur ho u rs fo llowin g challenge. C:H s \vd lin g ( I x 10 - -1 in ches ± SEM ) w;ts measured w ith :11l (.· ng inccr's mic ro m eter. n.csuh s arc ('xprcssed :lS tht' thickn css of 
the challeng ed ear minlls th e lhickn css of the ullch:l ll engcd ear. 
dpercen t de prcss io n was detcrmin ed using th e fo llowin g eq uarion: 
% depression = I _ swelling (expe ri mental) - swelling (negative control) X 100. 
swell ing (pos iti ve control) - swell ing (negative contro l) 
D ISC U SS IO N 
T he ex posure of ex perim ental anim als, and presum ab ly hum ans, 
to the e ffe cts of UVR [6- 8]. LPS [6]. burn t raum a 11 4), o r o the r 
types of inflammato ry stimuli 115-17) is known to result in a l-
teratio ns of the ir immuno logic fun ction . Contact h y persensitivity 
caused by the topi ca l applica tio n of skin-reactive chemi cals has 
been employed as a m odel ex pe rim en ta l sys tem in nun y o f these 
studies, with redu ctio n s in the in ten sity of the C H resp o n se be in g 
used as an indica to r of d epress io n o r suppress io n of immuno logic 
responsiveness [1 ,21. The presence of anti gen-specifi c suppressor 
T lym ph o cytes in the spleen s of th e contact- sen sitized, ex peri-
mental anim als has served as the ba sis for concludin g that the 
dominance o f ac tive su ppress io n is res po ns ibl e fo r the immu-
nolog ic ch an ges o bserved fo llowin g UVR exposure 11 8-21]. 
M ost types o f infla m m atory responses, rega rdless of the in-
ducin g stimu lus, a re para lled by ph ys io logic chan ges th at are 
believed to be ca used b y th e acti o n of IL-1 [1 0, 11] . T his knowl-
ed ge led u s to questi o n w h e the r so m e of th e immuno logic alte r-
ations obse rved in animal s unde rgoin g a severe inflammato r y 
respo nse mig ht be m ediated thro ug h a comm on IL-1-dep endent 
m echanis m . W e fou nd that mice g iven a py rogenic dose of senu-
purifi ed , o r recombinant IL-l , exhibi ted C H responses th at were 
far less intense than those o bserved in n o rm al anim als, supportin g 
the possibi lity ofa comm o n path way fo r infl amm atio n-associated 
d epress io n in immune res po nsiv en ess. 
Stud ies undertaken to esta blish the m ech anism(s) resp o n sible 
for t he depress io n in C H responses d etermined th at b o th t he 
no rm al an d IL- I-pretreated anim als ex hi bited equiva len t levels of 
C H-e ffecto r- cell as we ll as suppresso r-cel l ac ti v ity. T his is con-
sistent with o ur recen t findin gs on the m ech anism s res ponsib le 
for UVR-induced imll1unosup press io n 1131. T h ese studies esta b-
li shed th at UVR-ex posed anim als, con tact sens itized th ro u g h nor-
m al ski n s ites, were to ta ll y no rma l for C H-effecto r- and sup-
pressor-ceil gene ratio n . Fi nd in g that IL-l-treated anim als exhibit 
minim al C H responses fo llowin g the ad optive transfer o f C H-
effector cells o btained fro m no rm al, an tigen-p rim ed do n o rs su g-
ges ts t hat th e chan ges caused by I L-I associate w ith th e effec to r 
arm of the C H respon se. This o b se rva tio n was extended b y a 
d em o ns tratio n o f a redu ctio n in the number of rad io labeled ef-
Table VIII. Depression 111 Contact Hypersensiti v ity R es po nses Ca used b y sclL-1 o r Human R eco mbin ant IL-1 13 Is Abroga ted b y 
Treatin g the Ado ptive Recipien ts With Indo m ethacin 
Experiment # 
2 
Ado ptive T ransfer 
of DN FB-Scnsitized 
Lymphocy tes" 
+ 
+ 
+ 
+ 
+ 
+ 
T reatment o f Recipient Mice 
IL- I" 
+ 
+ 
+ 
+ 
Indomethac in' 
+ 
+ 
C hallenge" 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
D. Ea r Percent 
Swel ling' Depression( 
6 ± 2 
36 ± 0 
15 ± 70 
34 ± 7 
3 ± 0 
24 ± 2 0 
10 ± 0 67 
29 ± 3 0 
"D NFB-scnsitizcd ly m phocyte popula tions fro m all im als prepared ::IS ::Idoptivc t r:l nsfc r d onors as described ill JVlattTials a"d Atfcll'4,t/S. t::lch rccipicnt ::I nill1 ::1 l rcn..' ived 30 X 
10" cells bnec i ~iellt mice received 50 units of sclL- 1 (Exp. I) or 150 ng of hullIan recomb inant IL- I ~ (Exp. 2) 24 h before rece iving DNF13-scll si;ized lymphocytes. 
(Groups o f mi ce we re sllbclI t:m eo usly im planted w ith ind o l11cth:tci n pcllcts that relcase 2.5 }.Lg of dru g/day . Indo m c thaci n mice wc re rcstcd 48 h befo rc i.v. injectio n of 
IL-1. 
' necipient mice were ea r-chalk- Il ged with I () ,...1 of a 0.25% solutioll of DNFI3 in acetone: oli ve oil (4 : I) immediately fo llowing adopt ive transfer. 
'Twenty-four ho urs fo llowin g ch ::l ll cngc. car swellin g ( \ X \ 0 - .1 in ches ± SEM ) W:lS IHc:tsurcd w ith :t il en ginecr' s micro m eter . Result s arc ex prcssed as the thi ck ncss of 
the challenged ca r minus the thickness of the unchallenged ca r. 
(Percent dep ression was determined using the following equati on: 
swelling (experimenta l) - swel ling (nega ti ve control) 
% dep ression = I - X 100. 
swelling (posi ti ve control) - swelling (nega ti ve control) 
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Table IX. Interleukin 1 Appears to Exert its Immunomodulatory Effects on Contact Hypersensitivity Responses by its Capacity 
to Stimulate Prostaglandin Production 
Adoptive 
Transfer of Pretreatment of Recipient Mice Sensitized !l Ear Percent 
Group Lymphocytes" IL-1b AN PGE/ Indomethacin' Swelling! Depression" 
2 ± 0.4 0 
2 + 22 ± 0.4 0 
3 + + 8 ± 1.0 70 
4 + + + 22 + 1.0 0 
5 + + 8 ± 1.0 70 
6 + + + 21 ± 1.0 5 
7 + + 8 ± 1.0 70 
8 + + + 9 ± 1.0 65 
"Norma l C31-1 / HcN strain mice o r mi ce pretreated w ith IL-I. ara chidonic acid (AA), or pro5wgland ill E2 (PGE2) received 3n Lv. injectio n of 30 X 10(' lymph node 
lymphocytes from DNFB-primed normal syngeneic donors as described in Materia ls alld Metllods. Recipient mice were ca r-challenged with 10 p.1 of a 0.25% DNFB solution 
in 4: I acetone: olive oil. 
'Recombinant IL- I (150 ng) was i. v. injected 24 h before the adoptive transfer of sensiti zed lymphocytes. 
'Arachidonic acid pellets were subcutaneously implanted 72 h before adoptive transfer of sensitized lymphocytes. Each pellet has the capacit y to slowl y release 375 J.Lg/day 
of arachidonic acid over a 20-day period . 
' Mice were given subcutaneous injectio ns of 10 p.g PGE2 48 and 24 h before adoptive transfer of sensitized lymphocy tes. 
' Indomethacin pellets were implanted 72 h before adoptive transfer of sensiti zed lymp hocytes . Each pel let has the capacity to slowly release 1.25- 2.5 p.g/day of indo methacin 
over a 20-day period. 
'Twenty-four hours following challenge, ea r swelling was measu red with an engineer's micrometer. Results arc expressed as the difference between challenged ear minus 
unchallenged ear. 
' Percent depression was ca lculated using the following equation: 
swelling (experimental) - swelling (negative control) 
% depression = 1 - X 100. 
swelling (posit ive control) - swelling (negative control) 
fector cells capable 'of entering the site of skin challenge following 
IL-l pretreatment. We believe that these results indi cate that IL-
l is capable of altering the effector arm of the CH response through 
its capacity to diminish the abi lity of sensitized effector cells to 
enter sites of antigen deposition. C learly, this represents a very 
simple and logica l type of immune regul ation and probably in-
volves changes in endothelial cell receptiveness for anti gen-acti-
vated lymphocytes. It is well recognized that endothelial cells are 
responsive to the action of IL-1 [22-24) and are also capa ble of 
producing this cytokine [23,24]. 
The treatment of mice with a low, contin uo usly administered 
dose (1.25-2.5 /Lg/day) of indomethacin was found to abrogate 
the capacity of IL-1 to diminish host responses to CH induction. 
T his finding indica tes that the stimulated generation of prosta-
g landins by IL-l (25,26) is in some way involved in the alteration 
in CH responses observed. This finding is totally consistent with 
our recent observations that indomethacin therapy was capable 
of abrogatin g UVR-induced depression in CH responses [13). 
We have recently concluded a series of experiments that have 
determined that UVR- and LPS-, as well as IL-l-induced changes 
in CH responses are all mediated at the efferent level and , fur-
thermore, are all reversible by treatment with the drug indo-
methacin (R. Daynes et ai, manuscript in preparation). Finally, 
our results that demonstrate that the administration of arachidonic 
acid or prostaglandin E2 to normal mice causes a reduction in 
their capacity to mediate CH responses subsequent to the adoptive 
transfer of hapten-primed CH-effector cells, adds substantial sup-
port to our hypothesis . This finding is similar to the recent ob-
servation by Rheins and Nordlund [27], who demonstrated that 
the topical application of arachidonic acid to normal mice causes 
a reduction in their capacity to elicit CH responses following skin 
sensitization to CS agents through the exposed sites. 
Herein we describe a prostaglandin-dependent mechanism ca-
pable of interfering with the capacity of lymphocytes to localize 
to peripheral tissue sites. This provides a very general means to 
control those aspects of cell-mediated immune responses that are 
dependent on anatomic compartmentalization to achieve effector 
function. Having established a close linkage with inflammation 
and IL-l production, it is quite possible that a similar mechanism 
may be functioning in other types of experimental and clinical 
conditions. Immunodepression found in experimental animals with 
liver damage (1 6) or burn traum a [14), as well as animals having 
circulating antigen-antibody complexes [28,29) may all be due to 
a similar type of alteration in lymphocyte localization potential. 
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